|Brand :||Ayukriti Herbals|
|Product Code :||Platokriti|
|Reward Points :||1|
|Availability :||Out Of Stock|
Rs.195+ Rs.50 shipping
- Price in reward points : 195
PLATOKRITI JUICE actions that strengthen the immune system and increase the fighting ability of macrophages in the body that are responsible for combating micro-organisms & foreign bodies and therby boosts the immune system. It has excellent nutritive and rejuvenative value along with having anti-anaemic properties which increase the platelet count in blood.
Health Benefits (as mentioned in Ayurveda): Bears Preventive approach for Fever of varied etiology,combats infections, purifies blood and provokes stamina,heals wounds & subsides inflammation,accelerates blood count & prevents anaemia.
Ingredients: Vasa (Adhatoda vasica), Lf.:1200 mg, Giloy (Tinospora cordifolia), St.Bk.: 800 mg, Papita(Carica papaya),Fr.:500mg, Kali mirch (Piper nigrum),Fr.:500 mg, Nashpati (Pyrus communis),Fr.: 500 mg, Tulsi (Ocimum sanctum),Lf.:1500mg
Recommended Dosage: Take 2-3 teaspoonful with lukewarm water twice a day.
Caution: Pregnant and Nursing Mothers should not consume the juice.
NUTRACEUTICAL; NOT FOR MEDICINAL USE
This Product is not intend to diagnose, treat , cure or prevent any disease
Storage: Store in a cool dark place & refrigerate after opening . Sedimentation may occur due to natural fibres
Tags: PLATOKRITI JUICE buy online, PLATOKRITI JUICE shop online in india, PLATOKRITI JUICE price, PLATOKRITI JUICE uses, PLATOKRITI JUICE, platelets tonic, Platokriti thrombocytopenia platelets Chikungunya virus infection Chikungunya virus infection Symptoms chikungunya fever what is chikungunya dengue fever A mosquito-borne viral disease occurring in tropical and subtropical areas Dengue vaccine Dengue Fever Symptoms of Dengue Fever Sudden, high fever Severe headaches Pain behind the eyes Severe joint and muscle pain Fatigue Nausea Vomiting Skin rash, which appears two to five days after the onset of fever Mild bleeding (such a nose bleed, bleeding gums, or easy bruising Diagnosing Dengue Fever A disease caused by a plasmodium parasite, transmitted by the bite of infected mosquitoes. Malaria is a mosquito-borne infectious disease affecting humans and other animals caused by parasitic single-celled microorganisms belonging to the Plasmodium group. Malaria causes symptoms that typically include fever, tiredness, vomiting, and headaches. In severe cases it can cause yellow skin, seizures, coma, or death. Symptoms usually begin ten to fifteen days after being bitten by an infected mosquito. If not properly treated, people may have recurrences of the disease months later. In those who have recently survived an infection, reinfection usually causes milder symptoms. This partial resistance disappears over months to years if the person has no continuing exposure to malaria. The disease is most commonly transmitted by an infected female Anopheles mosquito. The mosquito bite introduces the parasites from the mosquito's saliva into a person's blood. The parasites travel to the liver where they mature and reproduce. Five species of Plasmodium can infect and be spread by humans. Most deaths are caused by P. falciparum because P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria. The species P. knowlesi rarely causes disease in humans. Malaria is typically diagnosed by the microscopic examination of blood using blood films, or with antigen-based rapid diagnostic tests. Methods that use the polymerase chain reaction to detect the parasite's DNA have been developed, but are not widely used in areas where malaria is common due to their cost and complexity. The risk of disease can be reduced by preventing mosquito bites through the use of mosquito nets and insect repellents, or with mosquito control measures such as spraying insecticides and draining standing water. Several medications are available to prevent malaria in travellers to areas where the disease is common. Occasional doses of the combination medication sulfadoxine/pyrimethamine are recommended in infants and after the first trimester of pregnancy in areas with high rates of malaria. Despite a need, no effective vaccine exists, although efforts to develop one are ongoing. The recommended treatment for malaria is a combination of antimalarial medications that includes an artemisinin. The second medication may be either mefloquine, lumefantrine, or sulfadoxine/pyrimethamine. Quinine along with doxycycline may be used if an artemisinin is not available. It is recommended that in areas where the disease is common, malaria is confirmed if possible before treatment is started due to concerns of increasing drug resistance. Resistance among the parasites has developed to several antimalarial medications; for example, chloroquine-resistant P. falciparum has spread to most malarial areas, and resistance to artemisinin has become a problem in some parts of Southeast Asia. The disease is widespread in the tropical and subtropical regions that exist in a broad band around the equator. This includes much of Sub-Saharan Africa, Asia, and Latin America. In 2016, there were 216 million cases of malaria worldwide resulting in an estimated 445, 000 to 731, 000 deaths. Approximately 90% of both cases and deaths occurred in Africa. Rates of disease have decreased from 2000 to 2015 by 37%,  but increased from 2014 during which there were 198 million cases. Malaria is commonly associated with poverty and has a major negative effect on economic development. In Africa, it is estimated to result in losses of US$12 billion a year due to increased healthcare costs, lost ability to work, and negative effects on tourism. dengue fever medicine